<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">46912864X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323133157.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e19920901xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00573495</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00573495</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="2">
   <subfield code="a">A screening programme for microalbuminuria at a diabetes clinic in Apulia, southern Italy</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[S. De Cosmo, L. Picaro, A. Greco, G. Viberti]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Microalbuminuria is a predictor of renal and cardiovascular disease in both type 1 (insulin-dependent) and type 2 (insulin-independent) diabetes. We report on a screening programme for microalbuminuria at a diabetes clinic in Italy. All diabetic patients without Albustix-positive proteinuria attending the clinic between April and September 1991 were screened. Microalbuminuria was defined as a urinary albumin/creatinine ratio, on an early morning sterile urine sample, &gt;3 in at least two consecutive urine collections. Three hundred and fifty patients, 45 (20 female, 25 female) type 1 and 305 (145 male, 160 female) type 2 diabetics, were examined. The age range was 18-42 years and 36-73 years and duration of diabetes 1-24 and 1-35 years for type 1 and type 2 diabetic patients respectively. Blood pressure, lipids, glycosylated haemoglobin, body mass index and insulin dose, where appropriate, were measured in all patients. Microalbuminuria was found in 8 (22%) of the type 1 diabetics. These patients had a longer duration of diabetes (17.5 vs 7.4 years,P&lt;0.001), higher diastolic blood pressure (86±2.1 vs 76±2.6 mmHg,P&lt;0.05) and an increased total serum cholesterol level (203±23 vs 180±25 mg/dl,P&lt;0.05) compared with diabetic patients with microalbuminuria. Of the type 2 diabetic patients 95 (33%) were found to have microalbuminuria and 210 (69%) nor-moalbumiuria. The prevalence of hypertension (defined blood pressure &gt;140/90 mmHg or antihypertensive treatment) and of dyslipidaemia (defined as total cholesterol &gt;200 and triglycerides &gt;170 or hypolipidaemic treatment) were significantly higher (P&lt;0.001 and 0.01 respectively) in patients with microalbuminuria. This study shows a prevalence of microalbuminuria in type 1 and type 2 diabetic patients similar to that reported in surveys of diabetes clinic outpatients in northern Europe. The association between microalbuminuria and recognized risk factors for cardiovascular and renal disease justifies screening programmes for microalbuminuria for early detection of &quot;at-risk” diabetic patients and for the implementation of preventive therapeutic measures.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1992</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Diabetes mellitus</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Diabetic nephropathy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Microalbuminuria</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Screening</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">De Cosmo</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Department of Endocrinology, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Picaro</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Department of Internal Medicine, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Greco</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Department of Internal Medicine, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Viberti</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Endocrinology, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Acta Diabetologica</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">29/3-4(1992-09-01), 234-236</subfield>
   <subfield code="x">0940-5429</subfield>
   <subfield code="q">29:3-4&lt;234</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">29</subfield>
   <subfield code="o">592</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00573495</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00573495</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">De Cosmo</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Department of Endocrinology, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Picaro</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Department of Internal Medicine, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Greco</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Department of Internal Medicine, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Viberti</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Endocrinology, IRCCS &quot;Casa Sollievo della Sofferenza” Hospital, Viale dei Cappuccini, I-71013, San Giovanni Rotondo, Foggia, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Acta Diabetologica</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">29/3-4(1992-09-01), 234-236</subfield>
   <subfield code="x">0940-5429</subfield>
   <subfield code="q">29:3-4&lt;234</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">29</subfield>
   <subfield code="o">592</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
